Asymmetry Capital Management, L.P. Buys Biomarin Pharmaceutical Inc, UnitedHealth Group Inc, ...
Investment company Asymmetry Capital Management, L.P. (Current Portfolio) buys Biomarin Pharmaceutical Inc, UnitedHealth Group Inc, AbbVie Inc, IQVIA Holdings Inc, Centene Corp, sells Alkermes PLC, Medtronic PLC, Insulet Corp, Hologic Inc, Sage Therapeutics Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Asymmetry Capital Management, L.P.. As of 2021Q4, Asymmetry Capital Management, L.P. owns 24 stocks with a total value of $188 million. These are the details of the buys and sells.
New Purchases: BMRN, UNH, ABBV, IQV, CNC, JNJ, NTRA, ARGX, APLS,
Added Positions: HZNP, KURA, ITOS, BLU, FOLD, RGLS, ISEE, MRTX,
Reduced Positions: DICE, AVDL, QTRX, ACRS, CYTK, PMVP, BLSA,
Sold Out: ALKS, MDT, PODD, HOLX, SAGE, ARNA, PTCT, AZN, KYMR, BAX, RNA, AVTX, GMTX, LRMR,
For the details of Asymmetry Capital Management, L.P.'s stock buys and sells,
go to https://www.gurufocus.com/guru/asymmetry+capital+management%2C+l.p./current-portfolio/portfolio
These are the top 5 holdings of Asymmetry Capital Management, L.P.
Biomarin Pharmaceutical Inc (BMRN) - 177,741 shares, 8.34% of the total portfolio. New Position
Horizon Therapeutics PLC (HZNP) - 137,610 shares, 7.87% of the total portfolio. Shares added by 451.57%
UnitedHealth Group Inc (UNH) - 26,844 shares, 7.16% of the total portfolio. New Position
AbbVie Inc (ABBV) - 94,448 shares, 6.79% of the total portfolio. New Position
IQVIA Holdings Inc (IQV) - 44,314 shares, 6.64% of the total portfolio. New Position
New Purchase: Biomarin Pharmaceutical Inc (BMRN)
Asymmetry Capital Management, L.P. initiated holding in Biomarin Pharmaceutical Inc. The purchase prices were between $71.72 and $91.47, with an estimated average price of $82.84. The stock is now traded at around $86.710000. The impact to a portfolio due to this purchase was 8.34%. The holding were 177,741 shares as of 2021-12-31.
New Purchase: UnitedHealth Group Inc (UNH)
Asymmetry Capital Management, L.P. initiated holding in UnitedHealth Group Inc. The purchase prices were between $387.01 and $505.58, with an estimated average price of $454.21. The stock is now traded at around $460.990000. The impact to a portfolio due to this purchase was 7.16%. The holding were 26,844 shares as of 2021-12-31.
New Purchase: AbbVie Inc (ABBV)
Asymmetry Capital Management, L.P. initiated holding in AbbVie Inc. The purchase prices were between $107.43 and $135.93, with an estimated average price of $118.5. The stock is now traded at around $136.780000. The impact to a portfolio due to this purchase was 6.79%. The holding were 94,448 shares as of 2021-12-31.
New Purchase: IQVIA Holdings Inc (IQV)
Asymmetry Capital Management, L.P. initiated holding in IQVIA Holdings Inc. The purchase prices were between $238.37 and $282.61, with an estimated average price of $260.16. The stock is now traded at around $242.320000. The impact to a portfolio due to this purchase was 6.64%. The holding were 44,314 shares as of 2021-12-31.
New Purchase: Centene Corp (CNC)
Asymmetry Capital Management, L.P. initiated holding in Centene Corp. The purchase prices were between $61.94 and $84.72, with an estimated average price of $73.64. The stock is now traded at around $78.690000. The impact to a portfolio due to this purchase was 6.48%. The holding were 148,254 shares as of 2021-12-31.
New Purchase: Johnson & Johnson (JNJ)
Asymmetry Capital Management, L.P. initiated holding in Johnson & Johnson. The purchase prices were between $155.93 and $173.01, with an estimated average price of $163.78. The stock is now traded at around $167.100000. The impact to a portfolio due to this purchase was 5.06%. The holding were 55,755 shares as of 2021-12-31.
Added: Horizon Therapeutics PLC (HZNP)
Asymmetry Capital Management, L.P. added to a holding in Horizon Therapeutics PLC by 451.57%. The purchase prices were between $98.56 and $119.91, with an estimated average price of $109. The stock is now traded at around $88.200000. The impact to a portfolio due to this purchase was 6.44%. The holding were 137,610 shares as of 2021-12-31.
Added: Kura Oncology Inc (KURA)
Asymmetry Capital Management, L.P. added to a holding in Kura Oncology Inc by 158.49%. The purchase prices were between $12.22 and $19.57, with an estimated average price of $16.12. The stock is now traded at around $13.140000. The impact to a portfolio due to this purchase was 2.29%. The holding were 502,275 shares as of 2021-12-31.
Added: ITeos Therapeutics Inc (ITOS)
Asymmetry Capital Management, L.P. added to a holding in ITeos Therapeutics Inc by 82.86%. The purchase prices were between $26.23 and $47.86, with an estimated average price of $33.65. The stock is now traded at around $38.150000. The impact to a portfolio due to this purchase was 1.17%. The holding were 104,755 shares as of 2021-12-31.
Added: Regulus Therapeutics Inc (RGLS)
Asymmetry Capital Management, L.P. added to a holding in Regulus Therapeutics Inc by 94.87%. The purchase prices were between $0.32 and $0.76, with an estimated average price of $0.44. The stock is now traded at around $0.260400. The impact to a portfolio due to this purchase was 0.22%. The holding were 2,731,044 shares as of 2021-12-31.
Sold Out: Alkermes PLC (ALKS)
Asymmetry Capital Management, L.P. sold out a holding in Alkermes PLC. The sale prices were between $21.47 and $32.08, with an estimated average price of $26.14.
Sold Out: Medtronic PLC (MDT)
Asymmetry Capital Management, L.P. sold out a holding in Medtronic PLC. The sale prices were between $99.53 and $127.75, with an estimated average price of $115.4.
Sold Out: Insulet Corp (PODD)
Asymmetry Capital Management, L.P. sold out a holding in Insulet Corp. The sale prices were between $255.32 and $318.29, with an estimated average price of $290.04.
Sold Out: Hologic Inc (HOLX)
Asymmetry Capital Management, L.P. sold out a holding in Hologic Inc. The sale prices were between $68.97 and $77.92, with an estimated average price of $73.59.
Sold Out: Sage Therapeutics Inc (SAGE)
Asymmetry Capital Management, L.P. sold out a holding in Sage Therapeutics Inc. The sale prices were between $37.06 and $47.11, with an estimated average price of $41.81.
Sold Out: Arena Pharmaceuticals Inc (ARNA)
Asymmetry Capital Management, L.P. sold out a holding in Arena Pharmaceuticals Inc. The sale prices were between $49.55 and $92.95, with an estimated average price of $66.26.
Here is the complete portfolio of Asymmetry Capital Management, L.P.. Also check out:
1. Asymmetry Capital Management, L.P.'s Undervalued Stocks
2. Asymmetry Capital Management, L.P.'s Top Growth Companies, and
3. Asymmetry Capital Management, L.P.'s High Yield stocks
4. Stocks that Asymmetry Capital Management, L.P. keeps buyingThis article first appeared on GuruFocus.
